[1]
A. H. Al-Shammari and Mohammed Abd Ali Shahadha, “The effect of Favipiravir on liver enzyme among patients with mild to moderate COVID-19 infection: A prospective cohort study ”, J Popl Ther Clin Pharmacol, vol. 29, no. 04, pp. 46–54, Dec. 2022, doi: 10.47750/jptcp.2022.967.